Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
None

SEDAR Interim Financial Statements

MGRO · Price
[
  {
    "companyName": "MustGrow Biologics Corp.",
    "reportingPeriodEnd": "2025-09-30",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": {
      "cashAndCashEquivalents": 3280419,
      "accountsReceivable": 182891,
      "inventory": 1938165,
      "prepaidExpensesAndDeposits": 272810,
      "totalCurrentAssets": 5674285,
      "equipment": 162418,
      "intangibleAssets": 187693,
      "rightOfUseAssets": 36376,
      "totalAssets": 6060772,
      "accountsPayableAndAccruedLiabilities": 2568014,
      "currentPortionOfLeaseLiability": 14462,
      "currentPortionOfLongTermDebt": 417991,
      "totalCurrentLiabilities": 3000467,
      "earnOutPayable": 0,
      "leaseLiability": 22838,
      "longTermDebt": 0,
      "convertibleDebentures": 128436,
      "totalLiabilities": 3151741,
      "shareCapital": 28268748,
      "contributedSurplus": 7968746,
      "deficit": -33328463,
      "totalEquity": 2909031,
      "cashPerShare": 0.0621,
      "workingCapitalPerShare": 0.0506
    },
    "incomeStatement": {
      "periods": {
        "threeMonthsEndedSep302025": {
          "salesRevenue": 789178,
          "costOfSales": -608623,
          "licenseRevenue": 0,
          "sellingExpenses": 419296,
          "marketingAndPromotion": 124367,
          "officeAndAdministration": 262113,
          "researchAndDevelopment": 154520,
          "regulatory": 97800,
          "corporateCommunications": 108738,
          "transferAgentFilingAndExchange": 45426,
          "patentExpenses": 48757,
          "professionalFees": 69186,
          "royaltyExpense": 39600,
          "depreciation": 13317,
          "stockBasedCompensation": 1219231,
          "totalExpenses": 2602351,
          "lossBeforeInterest": -2421796,
          "interestIncome": 2805,
          "financeCosts": -9168,
          "foreignExchangeGainLoss": -1355,
          "netLoss": -2429514,
          "totalComprehensiveLoss": -2429514,
          "netLossPerShareBasicAndDiluted": -0.04,
          "weightedAverageSharesOutstandingBasicAndDiluted": 54707128
        },
        "threeMonthsEndedSep302024": {
          "salesRevenue": 6682,
          "costOfSales": -3741,
          "licenseRevenue": 272500,
          "sellingExpenses": 0,
          "marketingAndPromotion": 85340,
          "officeAndAdministration": 252421,
          "researchAndDevelopment": 93533,
          "regulatory": 45570,
          "corporateCommunications": 44360,
          "transferAgentFilingAndExchange": 41913,
          "patentExpenses": 83301,
          "professionalFees": 48846,
          "royaltyExpense": 0,
          "depreciation": 0,
          "stockBasedCompensation": 1304505,
          "totalExpenses": 1999789,
          "lossBeforeInterest": -1724348,
          "interestIncome": 46230,
          "financeCosts": 0,
          "foreignExchangeGainLoss": -2827,
          "netLoss": -1680945,
          "totalComprehensiveLoss": -1680945,
          "netLossPerShareBasicAndDiluted": -0.03,
          "weightedAverageSharesOutstandingBasicAndDiluted": 51640610
        },
        "nineMonthsEndedSep302025": {
          "salesRevenue": 7420237,
          "costOfSales": -6103744,
          "licenseRevenue": 0,
          "sellingExpenses": 1472446,
          "marketingAndPromotion": 494065,
          "officeAndAdministration": 944953,
          "researchAndDevelopment": 358044,
          "regulatory": 265743,
          "corporateCommunications": 280852,
          "transferAgentFilingAndExchange": 201752,
          "patentExpenses": 98703,
          "professionalFees": 460782,
          "royaltyExpense": 247529,
          "depreciation": 37443,
          "stockBasedCompensation": 1324342,
          "totalExpenses": 6186654,
          "lossBeforeInterest": -4870161,
          "interestIncome": 20982,
          "financeCosts": -304410,
          "foreignExchangeGainLoss": -5135,
          "netLoss": -5158724,
          "totalComprehensiveLoss": -5158724,
          "netLossPerShareBasicAndDiluted": -0.10,
          "weightedAverageSharesOutstandingBasicAndDiluted": 52838165
        },
        "nineMonthsEndedSep302024": {
          "salesRevenue": 6682,
          "costOfSales": -3741,
          "licenseRevenue": 272500,
          "sellingExpenses": 0,
          "marketingAndPromotion": 350034,
          "officeAndAdministration": 790405,
          "researchAndDevelopment": 523013,
          "regulatory": 246823,
          "corporateCommunications": 173905,
          "transferAgentFilingAndExchange": 185564,
          "patentExpenses": 157617,
          "professionalFees": 258367,
          "royaltyExpense": 0,
          "depreciation": 0,
          "stockBasedCompensation": 1461336,
          "totalExpenses": 4147064,
          "lossBeforeInterest": -3871623,
          "interestIncome": 177381,
          "financeCosts": 0,
          "foreignExchangeGainLoss": 18562,
          "netLoss": -3675680,
          "totalComprehensiveLoss": -3675680,
          "netLossPerShareBasicAndDiluted": -0.07,
          "weightedAverageSharesOutstandingBasicAndDiluted": 51581168
        }
      }
    },
    "cashFlowStatement": {
      "periods": {
        "nineMonthsEndedSep302025": {
          "netLoss": -5158724,
          "stockBasedCompensation": 1324342,
          "deferredRevenue": 0,
          "depreciationExpense": 37443,
          "nonCashFinanceCosts": 110111,
          "changesInAccountsReceivable": -80115,
          "changesInInventory": -507942,
          "changesInPrepaidExpensesAndDeposits": -142925,
          "changesInAccountsPayableAndAccruedLiabilities": 227203,
          "cashUsedInOperatingActivities": -4190607,
          "purchaseOfEquipment": -10816,
          "cashUsedInInvestingActivities": -10816,
          "issuanceOfDebentureUnits": 2573075,
          "issuanceOf2025Units": 1889840,
          "exerciseOfStockOptions": 131447,
          "repaymentOfLongTermDebt": -100000,
          "paymentOfLeaseLiabilities": -10050,
          "cashUsedInProvidedByFinancingActivities": 4484312,
          "netIncreaseDecreaseInCash": 282889,
          "cashBeginningOfYear": 2997530,
          "cashEndOfPeriod": 3280419
        },
        "nineMonthsEndedSep302024": {
          "netLoss": -3675680,
          "stockBasedCompensation": 1461336,
          "deferredRevenue": -272500,
          "depreciationExpense": 0,
          "nonCashFinanceCosts": 0,
          "changesInAccountsReceivable": -56195,
          "changesInInventory": -408316,
          "changesInPrepaidExpensesAndDeposits": -155000,
          "changesInAccountsPayableAndAccruedLiabilities": 103270,
          "cashUsedInOperatingActivities": -3003085,
          "purchaseOfEquipment": 0,
          "cashUsedInInvestingActivities": 0,
          "issuanceOfDebentureUnits": 0,
          "issuanceOf2025Units": 0,
          "exerciseOfStockOptions": 0,
          "repaymentOfLongTermDebt": -241343,
          "paymentOfLeaseLiabilities": 0,
          "cashUsedInProvidedByFinancingActivities": -241343,
          "netIncreaseDecreaseInCash": -3244428,
          "cashBeginningOfYear": 6817169,
          "cashEndOfPeriod": 3572741
        }
      }
    },
    "investmentsAndOtherAssets": [],
    "shareStructure": {
      "authorizedShares": "Unlimited",
      "issuedShares": 58854357,
      "classesOfShares": ["common shares"],
      "warrants": [
        { "number": 1588410, "exercisePrice": 0.90, "expiryDate": "2030-01-16" },
        { "number": 133200, "exercisePrice": 1.90, "expiryDate": "2030-01-16" },
        { "number": 44800, "exercisePrice": 1.90, "expiryDate": "2027-01-16" },
        { "number": 3059731, "exercisePrice": 0.90, "expiryDate": "2030-08-28" },
        { "number": 123318, "exercisePrice": 0.90, "expiryDate": "2030-08-28" }
      ],
      "options": [
        { "number": 250000, "exercisePrice": 3.40, "expiryDate": "2027-03-14" },
        { "number": 50000, "exercisePrice": 2.10, "expiryDate": "2026-01-14" },
        { "number": 250000, "exercisePrice": 1.05, "expiryDate": "2025-12-14" }
      ],
      "rightsConvertibleInstruments": "Convertible debentures with conversion option at $1.50 per share"
    },
    "managementCompensation": {
      "currency": "CAD",
      "periods": {
        "threeMonthsEndedSep302025": {
          "consultingFeesAndOfficeRent": 245944,
          "stockBasedCompensation": 1115064
        },
        "threeMonthsEndedSep302024": {
          "consultingFeesAndOfficeRent": 240012,
          "stockBasedCompensation": 1130943
        },
        "nineMonthsEndedSep302025": {
          "consultingFeesAndOfficeRent": 748607,
          "stockBasedCompensation": 1125179
        },
        "nineMonthsEndedSep302024": {
          "consultingFeesAndOfficeRent": 698001,
          "stockBasedCompensation": 1197805
        }
      },
      "namedIndividuals": [],
      "otherRelatedPartyTransactions": []
    },
    "subsequentEvents": []
  }
]
Read the original news release →

More from Mustgrow Biologics Corp